Background: Drug-drug interactions (DDIs) are of great concern, as they are known to be related to adverse drug reactions and hospitalisations. In addition, many DDIs are regarded as predictable and avoidable; therefore, they may be considered as targets for education and interventions.
Objective: To analyse the relationship between number of dispensed drugs and the probability of potential DDIs among the elderly by using the new Swedish Prescribed Drug Register.
Methods: We analysed data on age, sex and dispensed drugs for people aged ≥75 years who were registered in the Swedish Prescribed Drug Register from October to December 2005, and constructed a list of current prescriptions for every individual on the arbitrarily chosen date of 31 December 2005. Thereafter, we included those who had at least two dispensed drugs to capture the elderly population at risk of being exposed to DDIs (n = 630 743). The main outcome measures were potentially clinically relevant DDIs (type C), which may require dose adjustment, and potentially serious DDIs (type D), which should be avoided.
Results: The prevalence of type C potential DDIs was 26% and of type D potential DDIs 5% in the study population. There was a strong association between number of dispensed drugs and the probability of type C potential DDIs and an even stronger association for type D potential DDIs, after adjustment for age and sex. In addition, the probability of type D potential DDIs decreased with increasing age, and women had a lower probability of type D potential DDIs than men.
Conclusion: There seems to be a strong relationship between number of dispensed drugs and potential DDIs, especially for potentially serious DDIs, which has implications for the importance of trying to minimise the number of drugs prescribed in the elderly. Our findings that the probability of potentially serious DDIs decreases with increasing age among the elderly and that elderly women have a lower probability of potentially serious DDIs than elderly men need to be verified and investigated by further research.
Herbal Drug Anatomical Therapeutic Chemical Classification Potential DDIs Require Dose Adjustment Frail Elderly Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
The authors have no conflicts of interest that are relevant to the content of this paper. This study was supported financially by the Swedish Council for Working Life and Social Research. We thank Johan Fastbom for help with the initialprocessing of the data material. We are also grateful to the National Board of Health and Welfare for providing us with the data.
Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003 Nov; 48(2): 133–43PubMedCrossRefGoogle Scholar
von Euler M, Eliasson E, Ohlen G, et al. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 2006 Mar; 15(3): 179–84CrossRefGoogle Scholar
Hamilton RA, Briceland LL, Andritz MH. Frequency of hospitalization after exposure to known drug-drug interactions in a Medicaid population. Pharmacotherapy 1998 Sep–Oct; 18(5): 1112–20PubMedGoogle Scholar
Haase G, Pietzsch M, Fahnrich A, et al. Results of a systematic adverse drug reaction (ADR)-screening concerning brady-cardia caused by drug interactions in departments of internal medicine in Rostock. Int J Clin Pharmacol Ther 2002 Mar; 40(3): 116–9PubMedGoogle Scholar
McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 2002 Sep; 36(9): 1331–6PubMedCrossRefGoogle Scholar
Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996 Aug; 44(8): 944–8PubMedGoogle Scholar
Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001 Dec; 38(6): 666–71PubMedCrossRefGoogle Scholar
Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003 Apr 2; 289(13): 1652–8PubMedCrossRefGoogle Scholar
Stanton LA, Peterson GM, Rumble RH, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994 Dec; 19(6): 341–7PubMedCrossRefGoogle Scholar
Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005; 22(1): 69–82PubMedCrossRefGoogle Scholar
Goldberg RM, Mabee J, Chan L, et al. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996 Sep; 14(5): 447–50PubMedCrossRefGoogle Scholar
Bergendal L, Friberg A, Schaffrath A. Potential drug-drug interactions in 5,125 mostly elderly out-patients in Gothenburg, Sweden. Pharm World Sci 1995 Sep 22; 17(5): 152–7PubMedCrossRefGoogle Scholar
Bjerrum L, Andersen M, Petersen G, et al. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003 Sep; 21(3): 153–8PubMedCrossRefGoogle Scholar
Bjorkman IK, Fastbom J, Schmidt IK, et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002 Nov; 36(11): 1675–81PubMedCrossRefGoogle Scholar
Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 2006 Jun; 4(2): 134–43PubMedCrossRefGoogle Scholar
Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000 Sep; 56(6–7): 501–9PubMedCrossRefGoogle Scholar
Fux R, Greiner D, Geldmacher M, et al. Multiple drug prescribing by general practitioners in a German region: Implications for drug interactions and patient safety. Int J Clin Pharmacol Ther 2006 Nov; 44(11): 539–47PubMedGoogle Scholar
Janchawee B, Wongpoowarak W, Owatranporn T, et al. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 2005 Feb; 30(1): 13–20PubMedCrossRefGoogle Scholar
Merlo J, Liedholm H, Lindblad U, et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001 Aug 25; 323(7310): 427–8PubMedCrossRefGoogle Scholar
Solberg LI, Hurley JS, Roberts MH, et al. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. Am J Manag Care 2004 Nov; 10 (11 Pt 1): 753–9PubMedGoogle Scholar
Gronroos PE, Irjala KM, Huupponen RK, et al. A medication database: a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol 1997; 53(1): 13–7PubMedCrossRefGoogle Scholar
World Health Organization. Drugs for the elderly. European Series, No. 17. Copenhagen: WHO Regional Publications, 1997Google Scholar
Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006 May; 61(5): 511–5PubMedCrossRefGoogle Scholar
Astrand B, Astrand E, Antonov K, et al. Detection of potential drug interactions: a model for a national pharmacy register. Eur J Clin Pharmacol 2006 Sep; 62(9): 749–56PubMedCrossRefGoogle Scholar
Kohler GI, Bode-Boger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000 Nov; 38(11): 504–13PubMedGoogle Scholar
Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 2006; 9(3): 427–33 918PubMedGoogle Scholar
Wettermark Hammar N, Michaelfored C, et al. The new Swedish prescribed drug register-opportunities for pharmaco-epidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007 Jul; 16(7): 726–35CrossRefGoogle Scholar
Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol 1997 May; 50(5): 619–25PubMedCrossRefGoogle Scholar
About the ATC/DDD system. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology [online]. Available from URL: http://www.whocc.no/atcddd/ [Accessed 2007 Apr 19]
Sjöqvist F. Drug Interactions (in Swedish) [online]. Available from URL: http://www.fass.se [Accessed 2007 Apr 19]
Giron MS, Wang HX, Bernsten C, et al. The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc 2001 Mar; 49(3): 277–83PubMedCrossRefGoogle Scholar
Glintborg B, Andersen SE, Dalhoff K. Drug-drug interactions among recently hospitalised patients: frequent but mostly clinically insignificant. Eur J Clin Pharmacol 2005 Oct; 61(9): 675–81PubMedCrossRefGoogle Scholar